(Q64131657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Latent tuberculosis infections in hard-to-reach drug using population-detection, prevention and control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

Lu-Yu Hwang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Carolyn Z Grimes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Palmer Beasley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Edward A Graviss

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

89 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

S41-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

Drug Dependence, A Possible New Risk Factor for Tuberculosis Disease

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Tuberculosis in drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Crack cocaine use and other risk factors for tuberculin positivity in drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Tuberculosis in the homeless. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

How does tuberculosis relate to HIV positive and HIV negative drug users?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

A cluster of tuberculosis among crack house contacts in San Mateo County, California

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Networks and tuberculosis: an undetected community outbreak involving public places.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

People and places: behavioral settings and personal network characteristics as correlates of needle sharing

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Viral hepatitis and other infectious diseases in a homeless population

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

1 reference

7 January 2021

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Comparison of a whole-blood interferon-γ assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

An assessment of the risks of syphilis and HIV infection among a sample of not-in-treatment drug users in Houston, Texas

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Sexual behaviour, STDs and drug use in a crack house population

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2809%2970010-1

7 January 2021

10.1016/S1472-9792(09)70010-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20006303%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference